{"id":"W2148504560","doi":"10.1200/jco.2011.34.5843","title":"Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Vinblastine; Vinca alkaloid; Chemotherapy; Refractory (planetary science); Surgery; Regimen; Glioma; Chemotherapy regimen; Internal medicine; Progression-free survival; Radiation therapy; Toxicity; Gastroenterology; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005261194,0.0005821807,0.001226043,0.0001745918,0.0001571904,0.0002955756,0.0005068429,0.0003916294,0.001152197],"category_scores_gemma":[0.0005169743,0.0001815678,0.0003464552,0.0002169834,0.000331582,0.0002285219,0.0001458254,0.001147549,0.0002578945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005446113,"about_ca_system_score_gemma":0.0006342131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009008161,"about_ca_topic_score_gemma":0.002297806,"domain_scores_codex":[0.9997568,0.0001190702,0.00001707653,0.00003555059,0.00002943237,0.00004214103],"domain_scores_gemma":[0.9995775,0.00008150099,0.0001406958,0.00002728276,0.0000225714,0.0001504699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2024671,0.04052576,0.08627969,0.002292406,0.002595059,0.0019806,0.001004659,0.007918145,0.2737872,0.000439399,0.004211459,0.3764986],"study_design_scores_gemma":[0.1209139,0.7088381,0.1089976,0.0001350488,0.001153162,0.004721424,0.0002327863,0.003328717,0.04143203,0.0001497171,0.0100546,0.0000428148],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978168,0.001389365,0.0002394185,0.00004732657,0.00001052905,0.0001822088,0.0000944894,0.00001831312,0.0002014824],"genre_scores_gemma":[0.9959056,0.00152954,0.001118598,0.0001140952,0.00004460417,0.0002687445,0.0007013702,0.00001183358,0.0003054259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001226043,"threshold_uncertainty_score":0.00395143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1648617106541613,"score_gpt":0.5032065506864968,"score_spread":0.3383448400323355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}